Skip to main content
. Author manuscript; available in PMC: 2022 Jan 15.
Published in final edited form as: Clin Cancer Res. 2021 Jun 8;27(14):4003–4011. doi: 10.1158/1078-0432.CCR-20-3458

Table 1.

CCND3 Mutations Identified in Pexidartinib Non-Responders

SAMPLE ID CHR POSITION GENE cDNA CHANGE PROTEIN CHANGE DEPTH VAF EFFECT
1_020_blasts 6 41903765 CCND3 c.792C>A p.S264R 753 0.065450644 Non synonymous codon
6 41903710 CCND3 c.847A>G p.T283A 835 0.141187926 Non synonymous codon
8_004_blasts (screen) 6 41903731 CCND3 c.826C>T p.Q276* 1174 0.338524035 Stop gained
8_004_wholeblood (C2D1) 6 41903731 CCND3 c.826C>T p.Q276* 1179 0.357380688 Stop gained
8_004_wholeblood (C4D1) 6 41903731 CCND3 c.826C>T p.Q276* 1302 0.394010113 Stop gained
8_004_blasts (EOT) 6 41903731 CCND3 c.826C>T p.Q276* 955 0.391138637 Stop gained